IBDEI0CB ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15603,1,4,0)
 ;;=4^I69.320
 ;;^UTILITY(U,$J,358.3,15603,2)
 ;;=^5007491
 ;;^UTILITY(U,$J,358.3,15604,0)
 ;;=I69.120^^47^703^3
 ;;^UTILITY(U,$J,358.3,15604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15604,1,3,0)
 ;;=3^Aphasia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,15604,1,4,0)
 ;;=4^I69.120
 ;;^UTILITY(U,$J,358.3,15604,2)
 ;;=^5007427
 ;;^UTILITY(U,$J,358.3,15605,0)
 ;;=I69.020^^47^703^4
 ;;^UTILITY(U,$J,358.3,15605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15605,1,3,0)
 ;;=3^Aphasia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,15605,1,4,0)
 ;;=4^I69.020
 ;;^UTILITY(U,$J,358.3,15605,2)
 ;;=^5007395
 ;;^UTILITY(U,$J,358.3,15606,0)
 ;;=I69.820^^47^703^5
 ;;^UTILITY(U,$J,358.3,15606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15606,1,3,0)
 ;;=3^Aphasia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,15606,1,4,0)
 ;;=4^I69.820
 ;;^UTILITY(U,$J,358.3,15606,2)
 ;;=^5007522
 ;;^UTILITY(U,$J,358.3,15607,0)
 ;;=I69.220^^47^703^6
 ;;^UTILITY(U,$J,358.3,15607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15607,1,3,0)
 ;;=3^Aphasia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,15607,1,4,0)
 ;;=4^I69.220
 ;;^UTILITY(U,$J,358.3,15607,2)
 ;;=^5007459
 ;;^UTILITY(U,$J,358.3,15608,0)
 ;;=I69.290^^47^703^11
 ;;^UTILITY(U,$J,358.3,15608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15608,1,3,0)
 ;;=3^Apraxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,15608,1,4,0)
 ;;=4^I69.290
 ;;^UTILITY(U,$J,358.3,15608,2)
 ;;=^5007484
 ;;^UTILITY(U,$J,358.3,15609,0)
 ;;=I69.390^^47^703^7
 ;;^UTILITY(U,$J,358.3,15609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15609,1,3,0)
 ;;=3^Apraxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,15609,1,4,0)
 ;;=4^I69.390
 ;;^UTILITY(U,$J,358.3,15609,2)
 ;;=^5007515
 ;;^UTILITY(U,$J,358.3,15610,0)
 ;;=I69.190^^47^703^8
 ;;^UTILITY(U,$J,358.3,15610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15610,1,3,0)
 ;;=3^Apraxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,15610,1,4,0)
 ;;=4^I69.190
 ;;^UTILITY(U,$J,358.3,15610,2)
 ;;=^5007452
 ;;^UTILITY(U,$J,358.3,15611,0)
 ;;=I69.090^^47^703^9
 ;;^UTILITY(U,$J,358.3,15611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15611,1,3,0)
 ;;=3^Apraxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,15611,1,4,0)
 ;;=4^I69.090
 ;;^UTILITY(U,$J,358.3,15611,2)
 ;;=^5007420
 ;;^UTILITY(U,$J,358.3,15612,0)
 ;;=I69.890^^47^703^10
 ;;^UTILITY(U,$J,358.3,15612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15612,1,3,0)
 ;;=3^Apraxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,15612,1,4,0)
 ;;=4^I69.890
 ;;^UTILITY(U,$J,358.3,15612,2)
 ;;=^5007546
 ;;^UTILITY(U,$J,358.3,15613,0)
 ;;=I69.393^^47^703^12
 ;;^UTILITY(U,$J,358.3,15613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15613,1,3,0)
 ;;=3^Ataxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,15613,1,4,0)
 ;;=4^I69.393
 ;;^UTILITY(U,$J,358.3,15613,2)
 ;;=^5007518
 ;;^UTILITY(U,$J,358.3,15614,0)
 ;;=I69.193^^47^703^13
 ;;^UTILITY(U,$J,358.3,15614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15614,1,3,0)
 ;;=3^Ataxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,15614,1,4,0)
 ;;=4^I69.193
 ;;^UTILITY(U,$J,358.3,15614,2)
 ;;=^5007455
 ;;^UTILITY(U,$J,358.3,15615,0)
 ;;=I69.293^^47^703^16
 ;;^UTILITY(U,$J,358.3,15615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15615,1,3,0)
 ;;=3^Ataxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,15615,1,4,0)
 ;;=4^I69.293
 ;;^UTILITY(U,$J,358.3,15615,2)
 ;;=^5007487
 ;;^UTILITY(U,$J,358.3,15616,0)
 ;;=I69.093^^47^703^14
 ;;^UTILITY(U,$J,358.3,15616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15616,1,3,0)
 ;;=3^Ataxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,15616,1,4,0)
 ;;=4^I69.093
 ;;^UTILITY(U,$J,358.3,15616,2)
 ;;=^5007423
 ;;^UTILITY(U,$J,358.3,15617,0)
 ;;=I69.893^^47^703^15
 ;;^UTILITY(U,$J,358.3,15617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15617,1,3,0)
 ;;=3^Ataxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,15617,1,4,0)
 ;;=4^I69.893
 ;;^UTILITY(U,$J,358.3,15617,2)
 ;;=^5007549
 ;;^UTILITY(U,$J,358.3,15618,0)
 ;;=I69.31^^47^703^17
 ;;^UTILITY(U,$J,358.3,15618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15618,1,3,0)
 ;;=3^Cognitive deficits following cerebral infarction
 ;;^UTILITY(U,$J,358.3,15618,1,4,0)
 ;;=4^I69.31
 ;;^UTILITY(U,$J,358.3,15618,2)
 ;;=^5007490
 ;;^UTILITY(U,$J,358.3,15619,0)
 ;;=I69.11^^47^703^18
 ;;^UTILITY(U,$J,358.3,15619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15619,1,3,0)
 ;;=3^Cognitive deficits following nontraumatic intcrbl hemorrhage
 ;;^UTILITY(U,$J,358.3,15619,1,4,0)
 ;;=4^I69.11
 ;;^UTILITY(U,$J,358.3,15619,2)
 ;;=^5007426
 ;;^UTILITY(U,$J,358.3,15620,0)
 ;;=I69.01^^47^703^19
 ;;^UTILITY(U,$J,358.3,15620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15620,1,3,0)
 ;;=3^Cognitive deficits following ntrm subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,15620,1,4,0)
 ;;=4^I69.01
 ;;^UTILITY(U,$J,358.3,15620,2)
 ;;=^5007394
 ;;^UTILITY(U,$J,358.3,15621,0)
 ;;=I69.81^^47^703^21
 ;;^UTILITY(U,$J,358.3,15621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15621,1,3,0)
 ;;=3^Cognitive deficits following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,15621,1,4,0)
 ;;=4^I69.81
 ;;^UTILITY(U,$J,358.3,15621,2)
 ;;=^5007521
 ;;^UTILITY(U,$J,358.3,15622,0)
 ;;=I69.21^^47^703^20
 ;;^UTILITY(U,$J,358.3,15622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15622,1,3,0)
 ;;=3^Cognitive deficits following oth ntrm intcrn hemorrhage
 ;;^UTILITY(U,$J,358.3,15622,1,4,0)
 ;;=4^I69.21
 ;;^UTILITY(U,$J,358.3,15622,2)
 ;;=^5007458
 ;;^UTILITY(U,$J,358.3,15623,0)
 ;;=I69.391^^47^703^22
 ;;^UTILITY(U,$J,358.3,15623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15623,1,3,0)
 ;;=3^Dysphagia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,15623,1,4,0)
 ;;=4^I69.391
 ;;^UTILITY(U,$J,358.3,15623,2)
 ;;=^5007516
 ;;^UTILITY(U,$J,358.3,15624,0)
 ;;=I69.191^^47^703^23
 ;;^UTILITY(U,$J,358.3,15624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15624,1,3,0)
 ;;=3^Dysphagia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,15624,1,4,0)
 ;;=4^I69.191
 ;;^UTILITY(U,$J,358.3,15624,2)
 ;;=^5007453
 ;;^UTILITY(U,$J,358.3,15625,0)
 ;;=I69.291^^47^703^25
 ;;^UTILITY(U,$J,358.3,15625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15625,1,3,0)
 ;;=3^Dysphagia following oth nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,15625,1,4,0)
 ;;=4^I69.291
 ;;^UTILITY(U,$J,358.3,15625,2)
 ;;=^5007485
 ;;^UTILITY(U,$J,358.3,15626,0)
 ;;=I69.091^^47^703^24
 ;;^UTILITY(U,$J,358.3,15626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15626,1,3,0)
 ;;=3^Dysphagia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,15626,1,4,0)
 ;;=4^I69.091
 ;;^UTILITY(U,$J,358.3,15626,2)
 ;;=^5007421
 ;;^UTILITY(U,$J,358.3,15627,0)
 ;;=I69.891^^47^703^26
 ;;^UTILITY(U,$J,358.3,15627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15627,1,3,0)
 ;;=3^Dysphagia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,15627,1,4,0)
 ;;=4^I69.891
 ;;^UTILITY(U,$J,358.3,15627,2)
 ;;=^5007547
 ;;^UTILITY(U,$J,358.3,15628,0)
 ;;=I69.321^^47^703^27
 ;;^UTILITY(U,$J,358.3,15628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15628,1,3,0)
 ;;=3^Dysphasia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,15628,1,4,0)
 ;;=4^I69.321
 ;;^UTILITY(U,$J,358.3,15628,2)
 ;;=^5007492
 ;;^UTILITY(U,$J,358.3,15629,0)
 ;;=I69.121^^47^703^28
 ;;^UTILITY(U,$J,358.3,15629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15629,1,3,0)
 ;;=3^Dysphasia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,15629,1,4,0)
 ;;=4^I69.121
 ;;^UTILITY(U,$J,358.3,15629,2)
 ;;=^5007428
 ;;^UTILITY(U,$J,358.3,15630,0)
 ;;=I69.021^^47^703^29
 ;;^UTILITY(U,$J,358.3,15630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15630,1,3,0)
 ;;=3^Dysphasia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,15630,1,4,0)
 ;;=4^I69.021
 ;;^UTILITY(U,$J,358.3,15630,2)
 ;;=^5007396
 ;;^UTILITY(U,$J,358.3,15631,0)
 ;;=I69.821^^47^703^31
 ;;^UTILITY(U,$J,358.3,15631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15631,1,3,0)
 ;;=3^Dysphasia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,15631,1,4,0)
 ;;=4^I69.821
 ;;^UTILITY(U,$J,358.3,15631,2)
 ;;=^5007523
 ;;^UTILITY(U,$J,358.3,15632,0)
 ;;=I69.221^^47^703^30
 ;;^UTILITY(U,$J,358.3,15632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15632,1,3,0)
 ;;=3^Dysphasia following oth nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,15632,1,4,0)
 ;;=4^I69.221
 ;;^UTILITY(U,$J,358.3,15632,2)
 ;;=^5007460
 ;;^UTILITY(U,$J,358.3,15633,0)
 ;;=G11.1^^47^703^32
 ;;^UTILITY(U,$J,358.3,15633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15633,1,3,0)
 ;;=3^Early-onset cerebellar ataxia
 ;;^UTILITY(U,$J,358.3,15633,1,4,0)
 ;;=4^G11.1
 ;;^UTILITY(U,$J,358.3,15633,2)
 ;;=^5003753
 ;;^UTILITY(U,$J,358.3,15634,0)
 ;;=I69.392^^47^703^33
 ;;^UTILITY(U,$J,358.3,15634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15634,1,3,0)
 ;;=3^Facial weakness following cerebral infarction
 ;;^UTILITY(U,$J,358.3,15634,1,4,0)
 ;;=4^I69.392
 ;;^UTILITY(U,$J,358.3,15634,2)
 ;;=^5007517
 ;;^UTILITY(U,$J,358.3,15635,0)
 ;;=I69.192^^47^703^34
 ;;^UTILITY(U,$J,358.3,15635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15635,1,3,0)
 ;;=3^Facial weakness following nontraumatic intcrbl hemorrhage
 ;;^UTILITY(U,$J,358.3,15635,1,4,0)
 ;;=4^I69.192
 ;;^UTILITY(U,$J,358.3,15635,2)
 ;;=^5007454
 ;;^UTILITY(U,$J,358.3,15636,0)
 ;;=I69.292^^47^703^36
 ;;^UTILITY(U,$J,358.3,15636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15636,1,3,0)
 ;;=3^Facial weakness following oth nontraumatic intcrn hemorrhage
